Marker Diagnostics will begin a study evaluating a saliva-based concussion test in women’s rugby players. The test, which is CE-certified for adult males, continues from research led by Dr Valentina Di Pietro and Professor Tony Belli at the University of Birmingham.
According to the UK-based company, MTx.100 is the world’s first diagnostic test for mild traumatic brain injury. The test measures expression of small non-coding RNA (sncRNA) biomarkers found in saliva to diagnose concussion. From a non-invasive mouth swab, the test will provide important information to healthcare professionals to assist in diagnosis and management of concussion. Analysis, which is conducted at a laboratory using qPCR, is completed within three hours with instant results available after.